Newly Reported Medicaid Outpatient Drugs, March 16-22, 2026

Newly reported, active covered outpatient drugs submitted by manufacturers to the Medicaid Drug Rebate Program (MDRP) database. The data was published by the U.S. Department of Health & Human Services on March 25, 2026. It captures additions reported since the last quarterly database update.

Use Cases

• Monitor recent drug market entries based on newly reported covered outpatient drugs.
• Analyze manufacturer reporting compliance for the Medicaid Drug Rebate Program.
• Track updates to the active drug formulary for outpatient coverage.

Strengths

• Data is sourced directly from the authoritative Medicaid Drug Rebate Program (MDRP) database.
• Provides a specific weekly snapshot for March 16-22, 2026, indicating recency.

Limitations

• Column-level documentation is absent; field semantics must be inferred after download.
• Row count is unknown, which may limit suitability assessment.
• Description metadata is limited; actual data quality requires manual inspection after download.

Provenance

Source

U.S. Department of Health & Human Services

Collection Method

Reported by participating drug manufacturers to the Medicaid Drug Rebate Program (MDRP) database.

Time Range

Covers drugs reported between March 16, 2026 and March 22, 2026.

Freshness

Last updated 2026-03-25 18:17:10.829522; freshness should be verified.

Geography

United States (inferred from program jurisdiction).